NCT07422805 2026-02-24
ctDNA
Institute of Oncology Ljubljana
Phase NA Completed
Clinical Trials
17 trialsNCT03225365 2025-09-17
IMMUNONIVO
Hospices Civils de Lyon
Phase NA Completed
NCT02831634 2025-09-08
NeoEpitope
Institut Curie
Phase NA Completed
NCT02278887 2025-03-10
TIL
The Netherlands Cancer Institute
Phase 3 Completed
NCT04253080 2024-01-09
ENZYMELA
Assistance Publique - Hôpitaux de Paris
Phase NA Unknown
NCT05029791 2023-12-15
COLEMAN
Hospices Civils de Lyon
Phase NA Recruiting
NCT02977052 2023-11-15
OpACIN-neo
The Netherlands Cancer Institute
Phase 2 Unknown
NCT03416933 2023-08-04
OPTIMEL
Institut de Cancérologie de Lorraine
Phase NA Completed
NCT03313544 2023-04-21
Evolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1
Assistance Publique Hopitaux De Marseille
Phase 4 Unknown
NCT02068196 2023-03-24
Ipi4
Oslo University Hospital
Phase 4 Active not recruiting
NCT02414750 2022-11-30
REPOSIT
Netherlands Working Group on Immunotherapy of Oncology
Phase 2 Terminated
NCT05062096 2022-10-04
NAKIMEL
Assistance Publique - Hôpitaux de Paris
Phase NA Unknown
NCT05426317 2022-06-22
Onco-PDL1s/B2M
University Hospital, Clermont-Ferrand
Phase NA Unknown
NCT03348891 2021-11-24
MELANFα
Institut Claudius Regaud
Phase NA Completed
NCT03787056 2021-07-16
ONCOPRO
Hospices Civils de Lyon
Phase NA Recruiting
NCT01916135 2020-04-27
PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT02105168 2016-06-10
MSN
Gustave Roussy, Cancer Campus, Grand Paris
Phase NA Unknown